Improving Radiation Conformality in the Treatment of Non–Small-Cell Lung Cancer
- 31 July 2010
- journal article
- review article
- Published by Elsevier BV in Seminars in Radiation Oncology
- Vol. 20 (3), 171-177
- https://doi.org/10.1016/j.semradonc.2010.01.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Intensity-Modulated Proton Therapy Reduces the Dose to Normal Tissue Compared With Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Radiotherapy for Extensive Stage IIIB Non-Small-Cell Lung Cancer: A Virtual Clinical StudyInternational Journal of Radiation Oncology*Biology*Physics, 2010
- On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription functionPhysics in Medicine & Biology, 2009
- Determination of patient-specific internal gross tumor volumes for lung cancer using four-dimensional computed tomographyRadiation Oncology, 2009
- Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Image–Guided Radiation Therapy for Non–small Cell Lung CancerJournal of Thoracic Oncology, 2008
- PD4-1-6: Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher dosesJournal of Thoracic Oncology, 2007
- Hypofractionated High-Dose Proton Beam Therapy for Stage I Non–Small-Cell Lung Cancer: Preliminary Results of A Phase I/II Clinical StudyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Four‐dimensional (4D) PET/CT imaging of the thoraxMedical Physics, 2004
- Hypofractionated Proton Beam Radiotherapy for Stage I Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinomaCancer, 2001